Comparison of two formulations of buprenorphine in cats administered by the oral transmucosal route

This randomised, blinded, cross-over study investigated the ease of oral transmucosal administration of two formulations of buprenorphine using glucose as a control in 12 cats. The cats received three treatments: buprenorphine multi-dose, buprenorphine and the equivalent volume of glucose 5%. Ease of treatment administration, observation of swallowing, changes in pupil size, sedation, salivation, vomiting, behaviour and food intake were assessed. The data were analysed using MLwiN and multi-level modelling. Ease of administration of buprenorphine multi-dose was statistically different from glucose (P <0.001), and the administration of all treatments became easier over the study periods. Swallowing was not statistically different between groups (P >0.05). Mydriasis was evident after the administration of both formulations of buprenorphine. Sedation, salivation, vomiting, behavioural changes or in-appetence were not observed after any treatment. Cats tolerated oral transmucosal administration of glucose better than buprenorphine multi-dose, while buprenorphine administration was tolerated as well as glucose.

[1]  Francesca Riccomini,et al.  BSAVA Manual of Canine and Feline Behavioural Medicine , 2011 .

[2]  I. Rodan.  Understanding feline behavior and application for appropriate handling and management. , 2010, Topics in companion animal medicine.

[3]  J. Ludders,et al.  Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes. , 2010, Veterinary anaesthesia and analgesia.

[4]  P. Steagall,et al.  Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy. , 2010, Veterinary anaesthesia and analgesia.

[5]  Sarah L. H. Ellis.  Environmental Enrichment: Practical Strategies for Improving Feline Welfare , 2009, Journal of feline medicine and surgery.

[6]  D. Mills,et al.  BSAVA manual of canine and feline behavioural medicine , 2009 .

[7]  P. Taylor,et al.  Thermal antinociception after dexmedetomidine administration in cats: A comparison between intramuscular and oral transmucosal administration , 2009, Journal of feline medicine and surgery.

[8]  M. Papich,et al.  Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration. , 2008, American journal of veterinary research.

[9]  P. Taylor,et al.  Thermal antinociception after dexmedetomidine administration in cats: a dose-finding study. , 2008, Journal of veterinary pharmacology and therapeutics.

[10]  N. Waran,et al.  A preliminary study of behaviour-based indicators of pain in cats , 2007, Animal Welfare.

[11]  J. Sear,et al.  Use of a transdermal matrix patch of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data , 2007, Veterinary Record.

[12]  P. Taylor,et al.  Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats. , 2006, Journal of veterinary pharmacology and therapeutics.

[13]  B. Rohrbach,et al.  Comparison of oral and subcutaneous administration of buprenorphine and meloxicam for preemptive analgesia in cats undergoing ovariohysterectomy. , 2005, Journal of the American Veterinary Medical Association.

[14]  J. Sear,et al.  PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. , 2005, Journal of veterinary pharmacology and therapeutics.

[15]  L. Tilley,et al.  The 5-Minute Veterinary Consult : Canine and Feline , 2005 .

[16]  P. Taylor,et al.  Pain management in cats—past, present and future. Part 1. The cat is unique , 2004, Journal of feline medicine and surgery.

[17]  P. Taylor,et al.  Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine , 2003, Veterinary Record.

[18]  J. Sear,et al.  Systemic uptake of buprenorphine by cats after oral mucosal administration , 2003, Veterinary Record.

[19]  P. Taylor,et al.  A thermal threshold testing device for evaluation of analgesics in cats. , 2002, Research in veterinary science.

[20]  K. Joubert.  The use of analgesic drugs by South African veterinarians. , 2001, Journal of the South African Veterinary Association.

[21]  A. Waterman-Pearson,et al.  Current British veterinary attitudes to perioperative analgesia for dogs , 1999, Veterinary Record.

[22]  K. Overall.  Clinical Behavioral Medicine for Small Animals , 1997 .

[23]  Reese T. Jones,et al.  Bioavailability of Sublingual Buprenorphine , 1997, Journal of clinical pharmacology.

[24]  D. Church,et al.  Use of anti-inflammatory and analgesic drugs in dogs and cats. , 1996, Australian veterinary journal.

[25]  I. Dohoo,et al.  Postoperative use of analgesics in dogs and cats by Canadian veterinarians. , 1996, The Canadian veterinary journal = La revue veterinaire canadienne.

[26]  Michael D. Lorenz,et al.  Small Animal Medical Diagnosis , 1995 .

[27]  K. Foley,et al.  Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.

[28]  A. Cowan,et al.  AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT , 1977, British journal of pharmacology.

[29]  L. Notari.  Stress in veterinary behavioural medicine , 2009 .

[30]  I. Rochlitz.  Basic requirements for good behavioural health and welfare in cats , 2009 .

[31]  B. Griffin,et al.  Recognition and Management of Stress in Housed Cats , 2006 .

[32]  S. Robertson.  Managing pain in feline patients. , 2005, The Veterinary clinics of North America. Small animal practice.

[33]  J. August.  Consultations in feline internal medicine 2. , 1991 .

[34]  S. Ettinger.  Textbook of Veterinary Internal Medicine , 1989 .